Profilo
Mr. Stephen M.
Hahn is a Chief Executive Officer at Nucleus Radiopharma, Inc. He is on the Board of Directors at Ion Beam Applications SA and Faeth Therapeutics, Inc. He received his undergraduate degree from William Marsh Rice University and a graduate degree from Temple University (Pennsylvania).
Posizioni attive di Stephen Hahn
| Società | Posizione | Inizio |
|---|---|---|
| ION BEAM APPLICATIONS, SA | Direttore/Membro del Consiglio | 16/06/2026 |
| FAETH THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 12/06/2026 |
Nucleus Radiopharma, Inc.
Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Amministratore Delegato | 20/08/2025 |
Formazione di Stephen Hahn
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Ion Beam Applications SA
Ion Beam Applications SA Medical SpecialtiesHealth Technology Supplies medical, dental and hospital equipment | Health Technology |
Rice University
Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Nucleus Radiopharma, Inc.
Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Health Technology |
















